<DOC>
	<DOCNO>NCT01671891</DOCNO>
	<brief_summary>Rectal cancer one common malignant tumor world . However , 's also reliable sensitive method monitor diseases evaluate therapy response till . Circulating tumor cell , could reflect tumor 's status correctly reliably , may promise method field . This study investigate role circulate tumor cell evaluate predict response chemoradiotherapy rectal cancer .</brief_summary>
	<brief_title>Detection Enumeration Circulating Tumor Cells Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Histologically verify rectal carcinoma Locally advance tumor ( cT34 and/or N+ transrectal ultrasound and/or pelvic magnetic resonance imaging ) distance anal verge &lt; = 12cm without metastasis Age 1875 year old ECOG PS 02 No previous chemotherapy radiotherapy rectal carcinoma Written inform consent histologically verify rectal carcinoma rectal cancer stage I distance verge &gt; 12cm age &lt; =18 &gt; =75 year old perform previously chemotherapy radiotherapy infection disease within three month serious disease write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>rectal cancer</keyword>
	<keyword>circulate tumor cell</keyword>
	<keyword>predict response</keyword>
</DOC>